US · Healthcare · Health Information Services
EPS came in at 0.07 against a street estimate of 0.08 — a miss of 12.5%.
Analysts rate Privia Health Group Inc a strong buy (19 buy, 2 hold, 0 sell out of 21) with an average price target of $31.67.
CONFIDENT Privia raised 2026 guidance across all metrics on strong H1 execution: 12.4% practice collections growth, 29% EBITDA growth, 5,644 providers across 25 states serving 6.1M patients. Margin expansion via AI and operational leverage positioning toward 30-35% EBITDA target. Q2 2026 Privia operates 1,300+ care center locations. Arizona seen as major growth state post-IMS acquisition. New Jersey entry marks 25th state. Analysts pressed on H2 growth deceleration (conservatism vs. headwinds), physician economics (15-50% uplift confirmed), MSSP changes (positive but requires consolidation), and AI spend management (measured by EBITDA margin accretion, not cost baseline). Management confident in execution but cautious on near-term guidance. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.92% |
| FMR Inc | 10.21% |
| Durable Capital Partners LP | 9.11% |
| Vanguard Portfolio Management, LLC | 4.92% |
| Rubicon Founders LLC | 4.66% |
| Vanguard Capital Management, LLC | 3.92% |
| State Street Corp | 3.52% |
| Van Berkom and Associates Inc | 2.91% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 PRIVIA HEALTH GROUP, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: August 12, 2026 (filed August 18, 2026) • Company: Privia Health Group, | 2026-08-18 |
| Quarterly report · Q2 2026 PRIVIA HEALTH GROUP, INC. – Q2 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Revenue (Q2 2026): $632.6 million vs. $521.2 million (Q2 2025) – 21.4% incr | 2026-08-06 |
| Results announced · Q3 2026 PRIVIA HEALTH GROUP, INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Net Income: $9.0M, up 236.7% from $2.7M in Q2 2025 • Q2 2026 Adjuste | 2026-08-06 |
| Board / officer change · Q3 2026 PRIVIA HEALTH GROUP, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • No financial metrics disclosed in this filing BUSINESS & SEGMENT HIGHLIGHTS • Compan | 2026-07-07 |
| Shareholder vote results · Q2 2026 PRIVIA HEALTH GROUP, INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held May 20, 2026 via live webcast • All three propos | 2026-05-22 |
| Quarterly report · Q1 2026 PRIVIA HEALTH GROUP, INC. – Q1 2026 10-Q SUMMARY --- HEADLINE NUMBERS • Revenue: $603.8 million (Q1 2026) vs. $480.1 million (Q1 2025) — 25.8% year | 2026-05-07 |
| Proxy statement · Q2 2026 PRIVIA HEALTH GROUP, INC. – 2026 PROXY SUMMARY --- CEO COMPENSATION • CEO Parth Mehrotra's 2025 total compensation: Not specified in provided docum | 2026-04-02 |
| Annual report FY2025 PRIVIA HEALTH GROUP, INC. – 2025 10-K SUMMARY HEADLINE NUMBERS • Company: Privia Health Group, Inc. (ticker: PRVA), Delaware corporation, headquarte | 2026-02-27 |
Readable in the app.
| Announcement | Date |
|---|---|
| Acquisition of Accountable Care Organization business from Evolent Health closed Privia Health Group completed its acquisition of an Accountable Care Organization (ACO) business from Evolent Health on December 5, 2025. The company had previously announced this definitive | 2025-12-08 |
| Definitive agreement to acquire Accountable Care Organization business for $100M Privia Health Group announced on September 23, 2025, that it is acquiring an Accountable Care Organization (ACO) business from Evolent Health for $100 million in upfront cash, plus up to $13 | 2025-09-23 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Privia Health Group Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.